Tag: TIGIT inhibitor clinical trials
iTeos ESMO Data: Promising Win for TIGIT in Nasdaq (ITOS)
iTeos Therapeutics (NASDAQ:ITOS) has been making significant strides in the field of immunotherapy, focusing on a molecule targeting TIGIT, a checkpoint with a complex...
Breaking Financial News
X’s New Terms of Service Causing Users to Leave Elon Musk’s...
Elon Musk's platform, X, has recently implemented new terms of service that have caused some users to leave the microblogging platform. These new terms...
